| 研究実績の概要 |
While there is robust evidence to suggest HPV vaccines are safe and effective, conveying the immense depth of scientific knowledge that supports the remarkable safety, efficacy and effectiveness of the HPV vaccines can be difficult. This is particularly the case in this age of social media, alternative facts and fake news, where unscientific, anti-vaccination claims travel quickly and can no longer be ignored. Unconfirmed reports of adverse events following immunization (AEFI) can lead to significant public anxiety. Events in Japan, Columbia, Denmark and now Ireland have illustrated the vulnerability of HPV vaccine uptake to perceptions of risk. In order to help both the general public and health care professionals understand the global situation of the HPV vaccine, three international symposium were held. International experts from countries who have implemented successful HPV vaccination programmes (Bhutan, Malaysia, Australia and the UK) as well as those from countries who are struggling (Denmark, Ireland and Japan) were invited. The first symposium was held at the WCE 2017 in Omiya, the second symposium, aimed at the media, was held at the Institute for Global Health Policy Research in Shinjuku and the third symposium was held in Hokkaido University, Sapporo. By sharing experiences and providing evidence based guidance on key technical and strategic issues, we hoped to present lessons learnt for other countries should they face similar difficulties, propose strategies to counter vaccination hesitancy and try and find a way forward for those countries still struggling.
|
